<DOC>
	<DOCNO>NCT02472769</DOCNO>
	<brief_summary>Two different dose level evaluate two different birth weight category , compare placebo regard safety tolerability .</brief_summary>
	<brief_title>IBP-9414 Prevention Necrotizing Enterocolitis</brief_title>
	<detailed_description />
	<mesh_term>Enterocolitis , Necrotizing</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<criteria>1 . Gestational age ≤32 week 2 . Birth weight : ) ≤ 2,000 g b ) ≤ 1,000 g. 3 . &lt; 48 hour age . 4 . Written informed consent patient 's legally authorize representative ( ) . 1 . Participation additional interventional clinical trial investigational drug administer . 2 . Infants extremis intensive care offer attend neonatologist ( e.g. , infant provide hospice/comfort care ) . 3 . Congenital acquire gastrointestinal pathology . 4 . Other condition infant , opinion attend neonatologist , preclude participation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>